Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease EP News Bureau Dec 30, 2020 Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH EP News Bureau Mar 5, 2020 Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…
